Phosphatidylserine (PS) is a negatively
charged lipid that plays
a critically important role in cell apoptosis. Under physiological
conditions, PS is localized on the cytosolic side of plasma membranes
via ATP-dependent flippase-mediated transport. A decrease in the ATP
levels in the cell, which is taken place upon pathological processes,
results in the increase in PS concentration on the exterior part of
the cell membranes. PS on the outer membrane surfaces attracts and
activates phagocytes, which trigger cell apoptosis. This programed
irreversible cell death is observed upon the progressive neurodegeneration,
a hallmark of numerous amyloid associated pathologies, such as diabetes
type 2 and Alzheimer’s disease. In this study, we investigate
the extent to which the rates of protein aggregation, which occurs
upon amyloid pathologies, can be altered by the concentration of PS
in large unilamellar vesicles (LUVs). We found that with an increase
in the concentration of PS from 20 to 40% relative to the concentration
of phosphatidylcholine and phosphatidylethanolamine, the rate of insulin
aggregation, protein linked to diabetes type 2, and injection amyloidosis
drastically increased. Furthermore, the concentration of PS in LUVs
determined the secondary structure of protein aggregates formed in
their presence. We also found that these structurally different aggregates
exerted distinctly different cell toxicities. These findings suggest
that a substantial decrease in cell viability, which is likely to
take place upon aging, results in the increase in the concentration
of PS in the outer plasma membranes, where it triggers the irreversible
self-assembly of amyloidogenic proteins, which, in turn, causes the
progressive neurodegeneration.